Literature DB >> 8652073

Effects of lesions to amygdala, ventral subiculum, medial prefrontal cortex, and nucleus accumbens on the reaction to novelty: implication for limbic-striatal interactions.

L H Burns1, L Annett, A E Kelley, B J Everitt, T W Robbins.   

Abstract

The effects of bilateral excitotoxic lesions of 3 major sources of afferents to the ventral striatum (nucleus accumbens) were compared on an open field test of food neophobia allowing the choice between familiar and novel food. Whereas lesions of the basolateral amygdala and ventral subiculum had qualitatively similar effects to reduce food neophobia (although not affecting the latency to eat), amygdala lesions increased and the ventral subiculum decreased locomotor activity. In contrast, damage to the ventromedial prelimbic prefrontal cortex only affected initial food choice and latency measures. By comparison, excitotoxic lesions of the nucleus accumbens itself and intra-accumbens infusion of the N-methyl-D-aspartate (NMDA) receptor antagonist AP5 increased activity and attenuated food neophobia. Results are discussed in terms of the role of limbic and prefrontal neuronal networks converging in the nucleus accumbens to control different aspects of the behavioral response to novelty.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652073     DOI: 10.1037//0735-7044.110.1.60

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  52 in total

1.  Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia.

Authors:  R Andrew Chambers; David W Self
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

2.  Differential hemodynamic response in affective circuitry with aging: an FMRI study of novelty, valence, and arousal.

Authors:  Yoshiya Moriguchi; Alyson Negreira; Mariann Weierich; Rebecca Dautoff; Bradford C Dickerson; Christopher I Wright; Lisa Feldman Barrett
Journal:  J Cogn Neurosci       Date:  2010-06-03       Impact factor: 3.225

3.  Variation in brain regions associated with fear and learning in contrasting climates.

Authors:  Timothy C Roth; Caitlin M Gallagher; Lara D LaDage; Vladimir V Pravosudov
Journal:  Brain Behav Evol       Date:  2012-01-26       Impact factor: 1.808

4.  Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5.

Authors:  M K Ahlijanian; N X Barrezueta; R D Williams; A Jakowski; K P Kowsz; S McCarthy; T Coskran; A Carlo; P A Seymour; J E Burkhardt; R B Nelson; J D McNeish
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats.

Authors:  J Yang; T R Sadler; T K Givrad; J-M I Maarek; D P Holschneider
Journal:  Neuroimage       Date:  2007-03-23       Impact factor: 6.556

Review 6.  The brain basis of emotion: a meta-analytic review.

Authors:  Kristen A Lindquist; Tor D Wager; Hedy Kober; Eliza Bliss-Moreau; Lisa Feldman Barrett
Journal:  Behav Brain Sci       Date:  2012-06       Impact factor: 12.579

7.  Distribution of serotonin transporter labeled fibers in amygdaloid subregions: implications for mood disorders.

Authors:  Howard O'Rourke; Julie L Fudge
Journal:  Biol Psychiatry       Date:  2006-01-18       Impact factor: 13.382

8.  Changes in serotonin metabolism in the rat brain on presentation of a habituated stimulus.

Authors:  G F Molodtsova
Journal:  Neurosci Behav Physiol       Date:  2005-07

9.  Basolateral amygdala is not critical for cognitive memory of contextual fear conditioning.

Authors:  A Vazdarjanova; J L McGaugh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Basolateral amygdala lesions do not prevent memory of context-footshock training.

Authors:  Daniel J Berlau; James L McGaugh
Journal:  Learn Mem       Date:  2003 Nov-Dec       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.